Skip to Content

Women No More Likely to Use Contraception After Diabetes Diagnosis

FRIDAY, March 26, 2021 -- Women are are no more likely to use contraception after a diabetes diagnosis, according to a study published online March 18 in Primary Care Diabetes.

Mara E. Murray Horwitz, M.D., from Harvard Medical School in Boston, and colleagues used private insurance data from nonpregnant women (aged 15 to 49 years; 2000 to 2014) to identify women with a new diabetes diagnosis (75,355 individuals) and a matched control group without diabetes (7.5 million individuals). Rates of prescription or procedural contraception use in the two groups were compared.

The researchers found that overall rates of contraception use did not increase in the year after diagnosis (absolute difference-in-difference, 0.4 percent). There was a decline noted in estrogen-containing and injectable contraceptives in the year after diagnosis (absolute difference-in-difference, −2.2 and −0.8 percent, respectively), although there were no corresponding increases for intrauterine contraception or subdermal implants.

"Our findings highlight the need for increased patient education, clinical support tools, and care coordination to improve access to family planning -- including the full range of safe and effective contraceptive options -- for women with diabetes," the authors write.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Diabetes Tied to Mortality, CV Events in Chronic Coronary Syndrome

THURSDAY, April 8, 2021 -- For patients with chronic coronary syndrome, the prevalence of diabetes varies but is associated with increased mortality and cardiovascular events,...

High Physical Activity, Low Air Pollution Exposure Cut T2DM Risk

TUESDAY, April 6, 2021 -- Higher levels of physical activity and lower levels of exposure to air pollution are associated with a lower risk for type 2 diabetes, according to a...

Cardiovascular Risk Factors Tied to Poor Pregnancy Outcomes

FRIDAY, April 2, 2021 -- Risk factors for heart disease put expectant mothers at higher risk for adverse pregnancy outcomes (APO) as well as increased chances of high blood...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.